---
category: news
title: "Tempus Announces Companion Diagnostic Collaboration With A2 Biotherapeutics"
excerpt: "Tempus, a leader in artificial intelligence and precision medicine, today announced a strategic collaboration to develop a companion diagnostic (CDx) test with A2 Biotherapeutics for its new therapy targeting patients with Loss of Heterozygosity (LOH)."
publishedDateTime: 2021-01-13T19:20:00Z
originalUrl: "https://apnews.com/press-release/business-wire/technology-medical-technology-tumors-diagnosis-and-treatment-health-bbd2bb37dd7b452b9f4f809dc702faf9"
webUrl: "https://apnews.com/press-release/business-wire/technology-medical-technology-tumors-diagnosis-and-treatment-health-bbd2bb37dd7b452b9f4f809dc702faf9"
type: article
quality: 22
heat: 22
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

related:
  - title: "HiberCell and Biodesix Initiate Broad Collaboration for Companion Diagnostic Discovery, Development and Commercialization"
    excerpt: "Initial program to focus on development of a companion diagnostic for HiberCellâ€™s novel immunotherapy, Imprime PGG, to aid in patient selection across multiple oncology programs Biodesix, Inc. (Nasdaq: BDSX) today announced an agreement with HiberCell,"
    publishedDateTime: 2021-01-13T12:25:00Z
    webUrl: "https://www.morningstar.com/news/business-wire/20210113005304/hibercell-and-biodesix-initiate-broad-collaboration-for-companion-diagnostic-discovery-development-and-commercialization"
    type: article
    provider:
      name: Morningstar, Inc.
      domain: morningstar.com
    quality: 0
  - title: "HiberCell and Biodesix Initiate Broad Collaboration for Companion Diagnostic Discovery, Development and Commercialization"
    excerpt: "Biodesix leverages multiple technologies with its proprietary artificial intelligence platform to discover, develop and commercialize diagnostic solutions for unmet clinical needs"
    publishedDateTime: 2021-01-14T06:43:00Z
    webUrl: "https://apnews.com/press-release/business-wire/technology-business-corporate-news-biotechnology-drug-trials-e1214f6c93aa4ac28fabaf54b6dd37be"
    type: article
    provider:
      name: Associated Press
      domain: apnews.com
    quality: 0

secured: "FhLRGUmIF8R62X+UeKidpt3xoLGeMXOgPDa1FmdvKcunQbV+BadoX0Pi5xCWvJcxP1MmxVvspqGSAF16EF6umy9w2Csz/BxoSjlqWrrehucov9H40pMAoMW9XoK3t2o4BRvq0GCZmt0jKGcPGHHRWXBJi0uiFeoj1LB24wUy2XGJWs57gCKBkBCplEmIUE2X62vLZXDSdNA3osGyc3yMGWUetnHSom+JkaKm43pv+hFZ8K75WRLP7DcnmcSSwxXaxqWrfA/rbnIWedXfXUYc1V6+ZVW3i+SEvvp+uZQcSpSxaSNaHPnBSCwlZ4n8RGEQFMXPTC2GZYjzJnMXMR9gMkeKv2rz0gFOVHnEf36W+1A=;yZWLN6fWIgBjuhWcGdpt3g=="
---

